Auditory P300 event-related potential in tobacco smokers

Güney, Figen; Genç, Bülent; Kutlu, Ruhuşen; İlhan, Bilge Çetin

doi:10.1016/j.jocn.2008.11.025

Cited by 23 publications

(18 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This fact, suggests that in the last decades N1 and N2 components have been studied as possible endophenotypes or bio-markers for different disorders and in some cases for recovery index: namely, in schizophrenia (Hegerl et al 1988;Haig et al 1997;Potts et al 1998a;Shelley et al 1999;Ford et al 2001;Brown et al 2002;Gilmore et al 2005;Neuhaus et al 2013), dementia (Verma et al 1989), Alzheimer (Sumi et al 2000), epilepsy and AED effects (Akaho 1996;Ford et al 2001;Lucchesi et al 2003), alcohol (Brigham et al 1997;Cohen et al 2002) and substance abuse (Tarter et al 1995;Brigham et al 1997), psychosis (Valkonen-Korhonen et al 2003), panic disorder (Wise et al 2009), Parkinson's disease (Wright et al (1996), ADHD (Johnstone et al 2001;Tsai et al 2012), stroke (Hirata et al 1996) and vascular cognitive impairment (van Harten et al 2006), myotonic dystrophy (Kazis et al 1996;Tanaka et al 2012), head injury (Reinvang et al 2000;Segalowitz et al 2001), (Guney et al 2009), amyotrophic lateral sclerosis (Ogawa et al 2009) and multiple sclerosis (Whelan et al 2010), more recently fragile X syndrome treatment (Schneider et al 2013), and bipolar disorder (Hamm et al 2013). …”

Section: Discussionmentioning

confidence: 99%

The development of the N1 and N2 components in auditory oddball paradigms: a systematic review with narrative analysis and suggested normative values

et al. 2014

View full text Add to dashboard Cite

Auditory event-related potentials (AERPs) are widely used in diverse fields of today's neuroscience, concerning auditory processing, speech perception, language acquisition, neurodevelopment, attention and cognition in normal aging, gender, developmental, neurologic and psychiatric disorders. However, its transposition to clinical practice has remained minimal. Mainly due to scarce literature on normative data across age, wide spectrum of results, variety of auditory stimuli used and to different neuropsychological meanings of AERPs components between authors. One of the most prominent AERP components studied in last decades was N1, which reflects auditory detection and discrimination. Subsequently, N2 indicates attention allocation and phonological analysis. The simultaneous analysis of N1 and N2 elicited by feasible novelty experimental paradigms, such as auditory oddball, seems an objective method to assess central auditory processing. The aim of this systematic review was to bring forward normative values for auditory oddball N1 and N2 components across age. EBSCO, PubMed, Web of Knowledge and Google Scholar were systematically searched for studies that elicited N1 and/or N2 by auditory oddball paradigm. A total of 2,764 papers were initially identified in the database, of which 19 resulted from hand search and additional references, between 1988 and 2013, last 25 years. A final total of 68 studies met the eligibility criteria with a total of 2,406 participants from control groups for N1 (age range 6.6-85 years; mean 34.42) and 1,507 for N2 (age range 9-85 years; mean 36.13). Polynomial regression analysis revealed that N1 latency decreases with aging at Fz and Cz, N1 amplitude at Cz decreases from childhood to adolescence and stabilizes after 30-40 years and at Fz the decrement finishes by 60 years and highly increases after this age. Regarding N2, latency did not covary with age but amplitude showed a significant decrement for both Cz and Fz. Results suggested reliable normative values for Cz and Fz electrode locations; however, changes in brain development and components topography over age should be considered in clinical practice.

show abstract

Section: Discussionmentioning

confidence: 99%

The development of the N1 and N2 components in auditory oddball paradigms: a systematic review with narrative analysis and suggested normative values

et al. 2014

View full text Add to dashboard Cite

show abstract

“…An amplitude reduction of the P300 ERP has been shown in subjects suffering from neuropsychiatric disorders such as alcoholism and schizophrenia and their unaffected relatives (Begleiter et al, 1984;Ramachandran et al, 1996;Cohen et al, 2002;Winterer et al, 2003;Hall et al, 2007). Cigarette smoking also affects P300 amplitude (Anokhin et al, 2000;Polich and Ochoa, 2004;Neuhaus et al, 2006;Guney et al, 2009). Of particular importance with regard to the endophenotype concept of P300 amplitude reduction in smokers was a study published by Iacono et al (2002) showing that reduced P300 amplitude at age 17 predicts nicotine dependence but also other substance use disorders three years later.…”

Section: Introductionmentioning

confidence: 99%

“…A number of studies have addressed the impact of smoking history on the P300 ERP (Anokhin et al, 2000;Iacono et al, 2002;Polich and Ochoa, 2004;Neuhaus et al, 2006;Yoon et al, 2006;Guney et al, 2009). In these studies a P300 amplitude reduction was found in smokers.…”

Section: Introductionmentioning

confidence: 99%

The P300 event-related potential and smoking — A population-based case–control study

Mobascher

Brinkmeyer

Warbrick

et al. 2010

International Journal of Psychophysiology

View full text Add to dashboard Cite

“…Numerous studies showed alterations of CEP P300 in neurological and psychiatric diseases, as well as consequences of traumatic damages of the brain, that is, craniocerebral injuries . Different substances that cause addiction, from alcohol and nicotine to various opiates, lead to changes in cognitive functions, including changes in P300 parameters, due to brain damage (54)(55)(56)(57)(58)(59)(60). Moreover, with P300 testing, damage of cognitive functions resulting from taking different medicines, especially antiepileptic drugs, can also be monitored (61)(62)(63).…”

Section: Discussionmentioning

confidence: 99%

“…Some studies reported changes in P300 amplitude and latency in cases of chronic consumption of nicotine, alcohol, as well as cannabis, opioids, cocaine, and ecstasy (Table 2) (8,(54)(55)(56)(57)(58)(59)(60).…”

Section: Review Of Literaturementioning

confidence: 99%

P300 as an auxiliary method in clinical practice: A review of literature

Titlić

Mihalj

Petrovic

et al. 2016

JHSCI

View full text Add to dashboard Cite

Cognitive functions can be assessed and followed up over a period of time with cognitive evoked potentials (CEP) P300� In this context, brainstem auditory evoked potentials (BAEP) are most commonly used, but visual evoked potentials (VEP) are utilized as well� The research in this area has demonstrated that these techniques could be used as a supplemental method in diagnostics of numerous diseases such as Alzheimer's disease, mild cognitive impairment, vascular dementia, epilepsy, craniocerebral trauma, Parkinson's disease, multiple sclerosis, and other degenerative diseases� In addition, P300 can also be used as an auxiliary method in the diagnostics of mental disorders conditions such as schizophrenia, panic disorders, narcotic drug addiction, nicotinism, alcoholism, etc� The method assists in monitoring the course of diseases leading to encephalopathy, such as liver and kidney damage and grave anaemia� The advantages of P300 testing are easy application, non-invasiveness, and an unlimited number of potential applications� Moreover, the results obtained with this method are measurable and can be compared�

show abstract

Auditory P300 event-related potential in tobacco smokers

Cited by 23 publications

References 49 publications

The development of the N1 and N2 components in auditory oddball paradigms: a systematic review with narrative analysis and suggested normative values

The development of the N1 and N2 components in auditory oddball paradigms: a systematic review with narrative analysis and suggested normative values

The P300 event-related potential and smoking — A population-based case–control study

P300 as an auxiliary method in clinical practice: A review of literature

Contact Info

Product

Resources

About